Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419985 · ClinicalTrials.gov registry record · Phase 2
Ketamine HCl Prolonged Release Oral Tablets for CRPS
A Phase 2 study, sponsored by University of Southern California.
- Not yet
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT06419985 is a Phase 2 study that has not yet begun recruiting, run by University of Southern California. The registered enrollment target is 65 participants.
The verdict
NCT06419985, a Phase 2 study, has not yet begun recruiting, sponsored by University of Southern California.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of Ketamine HCl Prolonged Release (PR) tablets in participants with pain due to complex regional pain syndrome (CRPS). Additionally, this trial will explore the feasibility of the trial design through dosing compliance, clinical instruments for safety and quality of life measurements, and pharmacokinetic profile.
Interventions
- DRUG 80mg/day Ketamine HCl Prolonged Release
- DRUG 160mg/day Ketamine HCl Prolonged Release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06419985
The ClinicalTrials.gov registry entry for NCT06419985 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 80mg/day Ketamine HCl Prolonged Release is the first listed.
NCT06419985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06419985 about?
NCT06419985 is a clinical study titled "Ketamine HCl Prolonged Release Oral Tablets for CRPS". The purpose of this study is to evaluate the efficacy of Ketamine HCl Prolonged Release (PR) tablets in participants with pain due to complex regional pain syndrome (CRPS). Additionally, this trial will explore the feasibility of the trial design through dosing compliance, clinical instruments for ...
What is the current status of trial NCT06419985?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2026-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT06419985?
The interventions under investigation include: 80mg/day Ketamine HCl Prolonged Release (DRUG), 160mg/day Ketamine HCl Prolonged Release (DRUG).
Who is sponsoring clinical trial NCT06419985?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.